前药
顺铂
体内
细胞毒性
乙二醇
A549电池
流出
癌细胞
药理学
生物物理学
生物化学
化学
材料科学
体外
化疗
癌症
生物
有机化学
遗传学
生物技术
作者
Anqi Shen,Xiangyong He,Shuo Tang,Tao Yu,Yuge Jiang,Song Gao,Linliang Deng,Taotian Wei,Miao Zhang,Rongfeng Hu,Yongling Wang,Shengqi Chen
标识
DOI:10.1021/acsami.4c21448
摘要
Drug resistance has emerged as a great challenge for achieving satisfactory therapeutic efficacy in platinum-based chemotherapy. Specifically, we synthesized a series of host defense peptide mimics with different degrees of polymerization (DP), i.e., poly(ethylene glycol)-poly(2-azepane ethyl methacrylate) (PEG45-PAEMAn, n = 8, 20, 43, 87, and 183), which displayed DP- and pH-dependent plasma membrane-disruptive capability and antitumor activity. Among these, PEG45-PAEMA43 exhibited the highest cytotoxicity at tumor acidity (pH 6.7), selectivity index, and in vivo antitumor activity, and was selected to encapsulate the hydrophobic Pt(IV) prodrug to form the PEG-PAEMA-Pt(IV) nanoprodrug. The nanoprodrug boosted the membrane-disruptive capability and antitumor activity of A549 and cisplatin-resistant A549/DDP cells at tumor acidity. Notably, it exhibited a much higher cellular uptake for A549/DDP cells and in vivo antitumor activity than PEG-PAEMA or cisplatin alone. This indicated that the PEG-PAEMA-Pt(IV) nanoprodrug could break the drug diffusion barrier posed by the cell membrane and disable even reverse efflux resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI